ATE208385T1 - 2,3-dihydro-1,4-benzodioxan-5-yl- piperazinderivate als 5-ht1a-antagonisten - Google Patents

2,3-dihydro-1,4-benzodioxan-5-yl- piperazinderivate als 5-ht1a-antagonisten

Info

Publication number
ATE208385T1
ATE208385T1 AT94201900T AT94201900T ATE208385T1 AT E208385 T1 ATE208385 T1 AT E208385T1 AT 94201900 T AT94201900 T AT 94201900T AT 94201900 T AT94201900 T AT 94201900T AT E208385 T1 ATE208385 T1 AT E208385T1
Authority
AT
Austria
Prior art keywords
benzodioxan
dihydro
piperazine derivatives
lower alkyl
value
Prior art date
Application number
AT94201900T
Other languages
English (en)
Inventor
Jan Hartog
Steen B J Van
Johannes Mos
Jacques Schipper
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Application granted granted Critical
Publication of ATE208385T1 publication Critical patent/ATE208385T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT94201900T 1993-07-05 1994-07-01 2,3-dihydro-1,4-benzodioxan-5-yl- piperazinderivate als 5-ht1a-antagonisten ATE208385T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93201950 1993-07-05

Publications (1)

Publication Number Publication Date
ATE208385T1 true ATE208385T1 (de) 2001-11-15

Family

ID=8213949

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94201900T ATE208385T1 (de) 1993-07-05 1994-07-01 2,3-dihydro-1,4-benzodioxan-5-yl- piperazinderivate als 5-ht1a-antagonisten

Country Status (21)

Country Link
US (1) US5462942A (de)
EP (1) EP0633260B1 (de)
JP (1) JP3572102B2 (de)
KR (1) KR100363988B1 (de)
CN (1) CN1044244C (de)
AT (1) ATE208385T1 (de)
AU (1) AU680900B2 (de)
CA (1) CA2127084C (de)
CZ (1) CZ286503B6 (de)
DE (1) DE69428943T2 (de)
DK (1) DK0633260T3 (de)
ES (1) ES2167346T3 (de)
FI (1) FI120306B (de)
HU (1) HU218215B (de)
IL (1) IL110209A (de)
NO (1) NO301980B1 (de)
NZ (1) NZ260891A (de)
PT (1) PT633260E (de)
RU (1) RU2118322C1 (de)
SK (1) SK281681B6 (de)
ZA (1) ZA944787B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0812196A4 (de) * 1995-02-23 1998-05-20 Merck & Co Inc Alpha 1a adrenergische rezeptorantagonisten
US5952351A (en) * 1995-02-23 1999-09-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US6096763A (en) * 1995-02-23 2000-08-01 Merck & Co., Inc. α1a adrenergic receptor antagonists
US5620997A (en) * 1995-05-31 1997-04-15 Warner-Lambert Company Isothiazolones
AU7734496A (en) * 1995-11-15 1997-06-05 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
US6001863A (en) * 1996-11-26 1999-12-14 Warner-Lambert Company Isothiazolones
TW530054B (en) 1997-09-24 2003-05-01 Duphar Int Res New piperazine and piperidine compounds
US6177566B1 (en) 1998-06-30 2001-01-23 Neurogen Corporation 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands
AR022303A1 (es) 1999-01-22 2002-09-04 Lundbeck & Co As H Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion
CN1081128C (zh) * 1999-08-18 2002-03-20 湖北省化学研究所 软性印刷电路板专用的高分子塑料薄膜双面复合金属板的制造方法
DE10031391A1 (de) * 2000-07-03 2002-02-07 Knoll Ag Bicyclische Verbindungen und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
CA2453837C (en) * 2001-07-20 2011-10-04 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder using eltoprazine and related compounds
KR20030084444A (ko) * 2002-04-26 2003-11-01 주식회사 파나진 Ｐｎａ 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
US20040058962A1 (en) * 2002-06-14 2004-03-25 Amedeo Leonardi Phenylalkylamines and pyridylalkylamines
US7153849B2 (en) * 2002-09-12 2006-12-26 Wyeth Antidepressant arylpiperazine derivatives of hetrocycle-fused benzodioxans
US20040215284A1 (en) * 2003-01-30 2004-10-28 Recordati S.A. Treatment of neuromuscular dysfunction of the lower urinary tract with selective mGlu5 antagonists
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
US9066903B2 (en) 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
CN111253335B (zh) * 2020-03-12 2023-06-06 浙江扬帆新材料股份有限公司 一种n-取代苯并异噻唑啉-3-酮衍生物的新合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2519986A1 (fr) * 1982-01-21 1983-07-22 Adir Nouveaux derives de benzodioxine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
GR79603B (de) * 1982-07-24 1984-10-31 Pfizer
JPS59118765A (ja) * 1982-12-24 1984-07-09 Fujisawa Pharmaceut Co Ltd ピペラジン誘導体
ZA848005B (en) * 1983-10-17 1985-05-29 Duphar Int Res Blood-pressure lowering piperazine derivatives
ATE44528T1 (de) * 1984-12-21 1989-07-15 Duphar Int Res Arzneimittel mit antipsychotischer wirkung.
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
DE3726425A1 (de) * 1987-03-18 1988-09-29 Bayer Ag Basisch substituierte saccharine
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
IL92544A0 (en) * 1988-12-08 1990-08-31 Duphar Int Res Piperazine derivatives,their preparation and pharmaceutical compositions containing them
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
JPH02184667A (ja) * 1989-01-11 1990-07-19 Meiji Seika Kaisha Ltd Ｎ，ｎ’―ジ置換ピペラジル誘導体及びそれを有効成分とする排尿障害改善剤
DE4127849A1 (de) * 1991-08-22 1993-02-25 Merck Patent Gmbh Benzodioxanderivate
GB9202915D0 (en) * 1992-02-12 1992-03-25 Wellcome Found Chemical compounds

Also Published As

Publication number Publication date
HU218215B (hu) 2000-06-28
ZA944787B (en) 1995-02-20
NO942471D0 (no) 1994-06-30
KR950003289A (ko) 1995-02-16
FI120306B (fi) 2009-09-15
CN1106813A (zh) 1995-08-16
NZ260891A (en) 1995-04-27
JPH07215972A (ja) 1995-08-15
AU6613994A (en) 1995-01-12
IL110209A0 (en) 1994-10-21
HUT75155A (en) 1997-04-28
SK78894A3 (en) 1995-03-08
EP0633260A1 (de) 1995-01-11
JP3572102B2 (ja) 2004-09-29
DK0633260T3 (da) 2002-02-25
HU9401965D0 (en) 1994-09-28
CZ286503B6 (en) 2000-04-12
FI943149A0 (fi) 1994-06-30
US5462942A (en) 1995-10-31
FI943149A (fi) 1995-01-06
RU2118322C1 (ru) 1998-08-27
IL110209A (en) 2000-02-29
CA2127084A1 (en) 1995-01-06
RU94023250A (ru) 1996-08-10
NO942471L (no) 1995-01-06
NO301980B1 (no) 1998-01-05
CZ159794A3 (en) 1995-05-17
KR100363988B1 (ko) 2003-02-05
CA2127084C (en) 2007-04-10
DE69428943T2 (de) 2002-08-01
AU680900B2 (en) 1997-08-14
PT633260E (pt) 2002-04-29
DE69428943D1 (de) 2001-12-13
EP0633260B1 (de) 2001-11-07
SK281681B6 (sk) 2001-06-11
CN1044244C (zh) 1999-07-21
ES2167346T3 (es) 2002-05-16

Similar Documents

Publication Publication Date Title
DE69428943D1 (de) 2,3-Dihydro-1,4-Benzodioxan-5-yl-piperazinderivate als 5-HT1A-Antagonisten
ES2188095T3 (es) Carboxamidas heterociclicas.
ES2054899T3 (es) Derivados de 2'-desoxi-5-fluorouridina.
FI881380A0 (fi) 1,4-disubstituerade piperazinfoereningar, deras framstaellning och anvaendning.
DE69717970T2 (de) Chinolin carbonsaure-derivate und ihre salze
ES2088410T3 (es) Fungicidas de acrilato.
DE69919436D1 (de) N-Acyl und N-Aroyl Aralkylamide
ATE89003T1 (de) Dioxaphosphorin-verbindungen und damit stabilisierte polyolefin-zusammensetzungen.
DE69119282T2 (de) Aminobenzolverbindungen, Herstellung und Verwendung
DE69017627T2 (de) Isochinolinderivate und ihre Salze als Proteasehemmer.
DE69213049T2 (de) Isoquinolinderivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee